Related Experiment Video
Updated: May 15, 2025

Surgical Treatment of an Endolymphatic Sac Tumor
Published on: May 26, 2023
[New systemic treatment approaches for malignant eyelid tumors]
Michael Simon1, Florian T Steinberg2, Constantin E Niederau2
1Zentrum für Augenheilkunde, Universität zu Köln, Medizinische Fakultät und Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland. michael.simon1@uk-koeln.de.
Abstract:
Malignant tumors of the eyelids represent a diagnostic and therapeutic challenge. Modern treatment approaches, such as targeted treatment and immunotherapy are becoming increasingly more important, particularly in advanced and metastatic stages; however, these can cause side effects such as fatigue, skin reactions and gastrointestinal complaints, which require close monitoring. An effective treatment option for advanced, metastasized or inoperable basal cell carcinoma is the well-manageable oral treatment with hedgehog inhibitors; however, these innovative, systemic treatment approaches require an individually adapted management, which is determined by an interdisciplinary tumor board and accompanied by a specialized, multiprofessional team to ensure optimal patient care.
Insights
Eyelid tumors pose diagnostic and therapeutic challenges. Advanced treatments like targeted therapy and immunotherapy, while effective, require careful management of side effects by specialized teams.
Area of Science:
- Oncology
- Dermatology
- Ophthalmology
Context:
- Malignant eyelid tumors present complex diagnostic and therapeutic challenges.
- Advanced and metastatic stages necessitate modern treatment modalities.
Purpose:
- To discuss the evolving treatment landscape for malignant eyelid tumors.
- To highlight the importance of managing side effects from targeted treatments and immunotherapy.
- To emphasize the role of hedgehog inhibitors in advanced basal cell carcinoma.
Summary:
- Modern treatments including targeted therapy and immunotherapy are crucial for advanced eyelid cancers but can cause significant side effects.
- Hedgehog inhibitors offer an effective oral treatment for advanced, metastatic, or inoperable basal cell carcinoma.
- Individualized patient management by interdisciplinary tumor boards and specialized teams is essential for optimal care.
Impact:
- Improved patient outcomes through tailored management of advanced eyelid malignancies.
- Enhanced understanding of side effect profiles and management strategies for novel cancer therapies.
- Facilitation of evidence-based, multidisciplinary care for complex oncological cases.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...

